A comparison of trends in mortality from primary liver cancer and intrahepatic cholangiocarcinoma in Europe.
about
Cholangiocarcinoma: Current Knowledge and New DevelopmentsAddition and Subtraction Theory of TCM Using Xiao-Chaihu-Decoction and Naturopathy in Predicting Survival Outcomes of Primary Liver Cancer Patients: A Prospective Cohort StudyMultigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups.Update on Treatment Options for Advanced Bile Duct Tumours: Radioembolisation for Advanced Cholangiocarcinoma.Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications.Triptolide induces apoptotic cell death of human cholangiocarcinoma cells through inhibition of myeloid cell leukemia-1.Cohort profile: cholangiocarcinoma screening and care program (CASCAP).MiR-21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTEN.Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial.Secular trends in the incidence of cholangiocarcinoma in the USA and the impact of misclassificationCholangiocarcinoma: Biology, Clinical Management, and Pharmacological Perspectives.Surveillance for early diagnosis of hepatocellular carcinoma: how best to do it?Promoter hypermethylation of SHOX2 and SEPT9 is a potential biomarker for minimally invasive diagnosis in adenocarcinomas of the biliary tract.Oxidative damage in the progression of chronic liver disease to hepatocellular carcinoma: an intricate pathway.Long-term trends in incidence and mortality of intrahepatic and extrahepatic bile duct cancer in Japan.Second-line chemotherapy in advanced biliary cancer: a systematic review.New Horizons for Precision Medicine in Biliary Tract Cancers.Gene alterations and epigenetic changes in intrahepatic cholangiocarcinoma.Acute hepatic porphyria and cancer risk: a nationwide cohort study.The Particular Story of Italians' Relation with Alcohol: Trends in Individuals' Consumption by Age and Beverage Type.Antitumor effect of FGFR inhibitors on a novel cholangiocarcinoma patient derived xenograft mouse model endogenously expressing an FGFR2-CCDC6 fusion protein.Time and deprivation trends in incidence of primary liver cancer subtypes in England.Identification of risk and prognostic factors for patients with clonorchiasis-associated intrahepatic cholangiocarcinoma.Temporal trends in liver-directed therapy of patients with intrahepatic cholangiocarcinoma in the United States: a population-based analysis.Cholangiocarcinoma - evolving concepts and therapeutic strategies.Upregulation of TCTP is associated with cholangiocarcinoma progression and metastasis.Suppression of 14-3-3ζ in cholangiocarcinoma cells inhibits proliferation through attenuated Akt activity, enhancing chemosensitivity to gemcitabine.Geographical differences in upper abdominal resectional surgery and high-volume procedures in Sweden during 2009-2011.Cancer mortality in Europe, 2005-2009, and an overview of trends since 1980.Identification of prognostic factors and the impact of palliative resection on survival of patients with stage IV hepatolithiasis-associated intrahepatic cholangiocarcinoma.Mortality Associated with Hepatobiliary Disease in Portugal between 2006 and 2012.Total Flavonoids from Oroxylum indicum Induce Apoptosis via PI3K/Akt/PTEN Signaling Pathway in Liver Cancer.
P2860
Q28076098-255B0064-7FA9-49A1-B2A2-1257E06C36A2Q30370015-49783285-AEF6-409D-8A12-10F5441D3BE1Q33757122-37A5EEB9-0CA2-4BE1-B845-B2EC4F96A7E9Q33844564-078694BB-7DEE-48C3-93C0-6A00A7468BF3Q34764681-BA3912C6-4FFE-4211-9CF0-20034CF8A197Q35151115-E10D95E8-ED1E-41EB-A27C-BA42B0593C9EQ35693985-552F76F5-3945-4617-A172-576F7C95B194Q35742436-C2A04E93-B32E-49D1-8B72-0869FAF72D69Q36287599-E437DC27-B04F-4A9F-B7E9-26E6B1FA4422Q36771685-D95E7D8D-71CD-4793-B030-61567CCB70ADQ36962011-C81C165F-8017-4F98-A9B5-EEEA06A72825Q37408912-E7D26E86-49BE-4F3C-882B-E35DC82A8FF7Q37497846-8B8EED6A-9112-4E7D-BC57-11329B154D9AQ37660654-DD9400BD-6098-4325-966E-4B758A2E819DQ37725159-AEB5E02E-29C5-4179-90FB-33E302CCF22AQ38207456-F7302914-E0F7-4A5D-8CDC-311C06061767Q38619219-B027CFC8-9325-4411-AE91-A0E361FBB456Q39022105-FBA6839F-5EFB-43BE-B166-C4B8528F4BFCQ40113705-BCE5CEB4-FB68-4679-A4D5-18235E233DD1Q40350420-EB14CDD1-1797-40EC-85F0-D993FEDDAC72Q41670809-1B8E223A-F35C-4635-B89A-F883DBAC356AQ42214199-A6624D00-DF5D-4661-B850-089EB6AB0FBAQ42221367-EAB01602-2964-44D4-80EB-17FFE1D179F0Q44905186-DBC3A35D-0511-45E5-8E4A-63BB34D053D1Q46087686-97E2D57B-54F3-4919-BC76-196121F484B7Q47134901-3A1A210D-96CF-4351-9359-75D4750A305CQ49234410-1560F874-5333-4909-8251-B1A6A718584FQ50186133-36ACB70C-3357-4BB6-BE54-F5A8AC884F43Q51217353-3CF36FF3-6625-4BD6-8CD7-0741C3E9C24DQ54483923-CD61509B-E744-4DDB-A87A-D163809BA740Q55360775-740D765A-4900-4237-B680-C545624F481CQ55437659-57FDB17B-D859-4C45-B80E-CCDF76537E47
P2860
A comparison of trends in mortality from primary liver cancer and intrahepatic cholangiocarcinoma in Europe.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
A comparison of trends in mort ...... cholangiocarcinoma in Europe.
@en
A comparison of trends in mort ...... cholangiocarcinoma in Europe.
@nl
type
label
A comparison of trends in mort ...... cholangiocarcinoma in Europe.
@en
A comparison of trends in mort ...... cholangiocarcinoma in Europe.
@nl
prefLabel
A comparison of trends in mort ...... cholangiocarcinoma in Europe.
@en
A comparison of trends in mort ...... cholangiocarcinoma in Europe.
@nl
P2860
P50
P356
P1433
P1476
A comparison of trends in mort ...... c cholangiocarcinoma in Europe
@en
P2093
P2860
P304
P356
10.1093/ANNONC/MDS652
P577
2013-02-01T00:00:00Z